Quote:

---

To register leronlimab (PRO 140) for potential approval from the local Food and Drug Administration to treat patients with COVID-19 in the Philippines.

---

The key here is what will take to local FDA to approve LL.

Is it pending USA FDA approval ??? If yes, it only means a possible quick small market after approval

Would Philippines approve on their own based on existing/future data ??? This will mean name recognition, some small extra revenue and more "free" data with larger numbers.

Right now: just a positive PR showing an optimistic outlook for our possibilities in COVID

Hope we have some news this week regarding CD12.